Breaking News Instant updates and real-time market news.

GILD

Gilead

$82.64

0.35 (0.43%)

06:05
09/21/17
09/21
06:05
09/21/17
06:05

Gilead receives approval in Canada for expanded indication of Epclusa

Gilead Sciences Canada announced that Health Canada has granted a Notice of Compliance, or NOC, for updated labeling of Epclusa, the first all-oral, pan-genotypic, once-daily single tablet regimen, or STR, for the treatment of adults with chronic hepatitis C virus, or HCV, infection, to include use in patients co-infected with HIV-1. Health Canada granted Epclusa an NOC in July 2016, for the treatment of adults with genotype 1-6 chronic HCV infection without cirrhosis or with compensated cirrhosis, or with decompensated cirrhosis in combination with ribavirin.

  • 12

    Feb

GILD Gilead
$82.64

0.35 (0.43%)

08/31/17
STPT
08/31/17
DOWNGRADE
STPT
Reduce
Standpoint downgrades Juno after 50% rally in two weeks
Standpoint Research analyst Ronnie Moas downgraded Juno Therapeutics (JUNO) to Reduce from Buy noting that the shares are up more than 50% in the past two weeks. Despite Juno being a takeover target following Kite Pharma's (KITE) agreement this week to be sold to Gilead Sciences (GILD), positions should be trimmed at current share levels, Moas writes in an email. The analyst points out that Juno's market capitalization is over $4B even though no earnings are being generated. The stock in early trading is up 5%, or $1.98, to 42.27.
09/05/17
FBCO
09/05/17
NO CHANGE
FBCO
Outperform
No read through to Gilead, Kite from Cellectis clinical hold, says Credit Suisse
Credit Suisse analyst Alethia Young said the safety issues that Cellectis (CLLS) is encountering, and which prompted a clinical hold be placed on the company's allogenic CAR-T drug, UCART123, could be to some degree related to the company's platform. She adds that CRS, which led to a death in Cellectis' BPDCN study, is a known issue with CAR-T technologies and cases have been seen in Juno (JUNO) and Kite's (KITE) programs as well. The analyst, who doesn't think there is a read through to Kite and Gilead (GILD) from the Cellectis news and remains confident Kite will receive approval later this fall and launch Axi-Cel, keeps an Outpeform rating on Gilead shares.
09/14/17
RBCM
09/14/17
INITIATION
Target $94
RBCM
Outperform
Gilead initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Gilead Sciences with an Outperform rating and $94 price target.
09/18/17
SBSH
09/18/17
NO CHANGE
Target $180
SBSH
Neutral
Citi does not expect higher bid for Kite Pharma
Citi analyst Robyn Karnauskas expects Kite Pharma's (KITE) takeover by Gilead Sciences (GILD) to get done and does not anticipate a higher bid emerging. The analyst raised her price target for Kite shares to $180 from $87 and keeps a Neutral rating on the name.

TODAY'S FREE FLY STORIES

BWXT

BWX Technologies

$64.12

-0.19 (-0.30%)

06:49
02/20/18
02/20
06:49
02/20/18
06:49
Hot Stocks
BWX Technologies subsidary awarded contracts for C$30M »

BWX Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

WMT

Walmart

$104.78

1.55 (1.50%)

06:48
02/20/18
02/20
06:48
02/20/18
06:48
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart sees FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

WMT

Walmart

$104.78

1.55 (1.50%)

06:48
02/20/18
02/20
06:48
02/20/18
06:48
Hot Stocks
Walmart says moving to annual guidance framework with quarterly updates »

Walmart also commented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

SLDB

Solid Biosciences

$24.93

-1.34 (-5.10%)

, SRPT

Sarepta

$64.00

0.86 (1.36%)

06:48
02/20/18
02/20
06:48
02/20/18
06:48
Initiation
Solid Biosciences, Sarepta initiated  »

Solid Biosciences…

SLDB

Solid Biosciences

$24.93

-1.34 (-5.10%)

SRPT

Sarepta

$64.00

0.86 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

USO

United States Oil Fund

$12.38

0.05 (0.41%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVPT

Travelport

$13.22

0.14 (1.07%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Earnings
Travelport reports Q4 adj. EPS 35c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 30

    May

WMT

Walmart

$104.78

1.55 (1.50%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Earnings
Walmart sees FY19 net sales growth 1.5%-2%, consensus $511.94B »

Sees FY19 effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

CDXC

ChromaDex

$5.39

0.01 (0.19%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Hot Stocks
ChromaDex announces two new collaborative human clinical studies on NIAGEN »

ChromaDex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

XOP

SPDR Oil Exploration and Production Fund

$33.92

-0.17 (-0.50%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$83.31

0.37 (0.45%)

06:47
02/20/18
02/20
06:47
02/20/18
06:47
Earnings
Medtronic backs FY18 adjusted EPS growth view of 9%-10%, consensus $4.77 »

In fiscal year 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 23

    Mar

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$31.88

0.71 (2.28%)

06:46
02/20/18
02/20
06:46
02/20/18
06:46
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGS

PlayAGS

$19.95

0.11 (0.55%)

06:46
02/20/18
02/20
06:46
02/20/18
06:46
Initiation
PlayAGS initiated  »

PlayAGS initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$23.31

-0.01 (-0.04%)

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Hot Stocks
Tailored Brands launches three week custom delivery »

Men's Wearhouse and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

TFX

Teleflex

$267.89

2.28 (0.86%)

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Hot Stocks
Teleflex subsidiary announces FDA cleared new indication for UroLift »

NeoTract, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

  • 01

    Mar

  • 14

    Mar

ADM

Archer Daniels

$43.13

0.265 (0.62%)

, SYT

Syngenta

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Periodicals
ADM, Syngenta settle lawsuit over biotech corn exports to China, Reuters reports »

Archer Daniels Midland…

ADM

Archer Daniels

$43.13

0.265 (0.62%)

SYT

Syngenta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$83.31

0.37 (0.45%)

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Earnings
Medtronic reports Q3 adjusted EPS $1.17, consensus $1.17 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 23

    Mar

UGAZ

VelocityShares 3x Long Natural Gas ETN

$52.20

-1.3 (-2.43%)

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$30.36

1.28 (4.40%)

06:45
02/20/18
02/20
06:45
02/20/18
06:45
Initiation
PagSeguro Digital initiated  »

PagSeguro Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$54.90

1.25 (2.33%)

, EGRX

Eagle Pharmaceuticals

$64.78

-0.07 (-0.11%)

06:44
02/20/18
02/20
06:44
02/20/18
06:44
Hot Stocks
Aerie Pharmaceuticals appoints John LaRocca as General Counsel »

Aerie Pharmaceuticals…

AERI

Aerie Pharmaceuticals

$54.90

1.25 (2.33%)

EGRX

Eagle Pharmaceuticals

$64.78

-0.07 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 28

    Feb

  • 05

    Apr

EWZ

MSCI Brazil Index

$45.54

0.03 (0.07%)

06:43
02/20/18
02/20
06:43
02/20/18
06:43
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCMGY

Newcrest Mining

$17.47

-0.87 (-4.74%)

06:43
02/20/18
02/20
06:43
02/20/18
06:43
Upgrade
Newcrest Mining rating change  »

Newcrest Mining upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$71.42

0.32 (0.45%)

06:43
02/20/18
02/20
06:43
02/20/18
06:43
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$36.32

0.18 (0.50%)

06:42
02/20/18
02/20
06:42
02/20/18
06:42
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$11.89

0.69 (6.16%)

06:42
02/20/18
02/20
06:42
02/20/18
06:42
Earnings
Kirkland's sees FY17 EPS 32c-34c, consensus 52c »

Based on Q4 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.09

-0.14 (-1.52%)

06:42
02/20/18
02/20
06:42
02/20/18
06:42
Hot Stocks
Transocean receives approvals, commences acquisition of remaining Songa shares »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.